sinjie

What to watch in the biomedical space over the next five years

The pandemic has brought the spotlight onto the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital health. Yet, the silver lining has dulled investors’ sentiments post-COVID. Increasingly, investors have become more cautious against macroeconomic headwinds, and many are expecting a correction in company valuations across all sectors.

EDBI Commemorates 30 Years of Investing to Shape Singapore’s Future

EDBI Commemorates 30 Years of Investing to Shape Singapore’s Future EDBI’s 30th Anniversary E-Book, entitled “30 years of Investing to Shape Singapore’s Future”, encapsulates our key milestones and charts our evolution as we drove the development of the manufacturing sector in the 1990s, seeded the biomedical industry through an emphasis on R&D and innovation in …

EDBI Commemorates 30 Years of Investing to Shape Singapore’s Future Read More »

Homegrown Mooring Solutions Provider Mooreast Holdings IPOs on SGX Catalist

Homegrown Mooring Solutions Provider, Mooreast Holdings Ltd., to Raise Total Gross Proceeds of S$8.5M from SGX Catalist IPO Offering of 800,000 Offer Shares at S$0.22 each and Placement of 38,050,000 Placement Shares at S$0.22 each Mooreast has received pre-IPO funding from Singapore-based global investor EDBI IPO Proceeds to fund Mooreast’s growth strategies to become a …

Homegrown Mooring Solutions Provider Mooreast Holdings IPOs on SGX Catalist Read More »